coronavirus
-
InflaRx Covid-19 Drug Welcomes an FDA Win; Pardes Bio Throws In the Towel
The FDA granted emergency use authorization to an InflaRx antibody drug that treats hospitalized Covid-19 patients. But Pardes Bioscience’s coronavirus journey is ending following the Phase 2 failure of an antiviral that was expected to compete with Pfizer’s Paxlovid.
-
Survey: Americans Are Split on the Covid-19 Public Health Emergency
About 51% of U.S. adults are in favor of the Covid-19 public health emergency still in effect, while 39% said it is no longer needed, a recent Morning Consult survey found. Americans’ opinions varied based on political party, generation, race/ethnicity and location.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Healthcare leaders: disorganization, disparities characterized health crisis
Reflecting on lessons learned from the pandemic, healthcare leaders pointed to the lack of coordination and glaring health disparities that hampered the U.S. pandemic response. Going forward, they hope to see future change in the healthcare system.
-
MedCity Influencers, Artificial Intelligence
We can’t blame AI when humans mess up
If we continue to apply the technology without widespread agreement to these basic premises, we could dissolve people’s trust before we even earn it.
-
Searching for vaccine information? Google wants to make it easier to find
As states begin to roll out vaccines to the broader public, Google will make it easier for people to find out when they are eligible and where they can get a vaccine. The effort is part of a broader push, including $150 million in grants to promote vaccine education and equitable access.
-
Beckman Coulter seeks authorization for $4 antigen test
Beckman Coulter said it would file for an emergency use authorization for a SARS-CoV-2 antigen test that costs only $4.
-
Pediatricians want kids to be part of Covid vaccine trials
Covid-19’s impact on children represents a tiny fraction of the suffering and death experienced by vulnerable adults. Yet it’s pretty serious having caused 154 deaths and more than 7,500 hospitalizations as of Dec. 3 among people 19 and younger in the United States.
-
FDA ok’s over-the-counter home test for Covid-19
The FDA authorized an at-home antigen test for Covid-19 developed by Ellume. It does not require a prescription.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Hospitals scramble to prioritize which workers are first for Covid Shots
Even as FDA engaged in intense deliberations ahead of Friday’s authorization of the Pfizer and BioNTech Covid vaccine, and days before the initial 6.4 million doses were to be released, hospitals across the country have been grappling with how to distribute the first scarce shots.
-
FDA gives emergency OK to Pfizer and BioNTech vaccine
The vaccine was developed in record time, a big scientific accomplishment, even though the agency’s move follows an unusual level of pressure from President Trump’s White House, renewing concerns that politics drove the vaccine process even as the first doses are shipped.
-
FDA panel backs use of Pfizer/BioNTech vaccine for Covid-19
The nonbinding recommendation is a final hurdle before an official emergency use authorization for the vaccine, which could be the first shot approved for use in the U.S. Distribution, however, will remain a challenge.
-
Health IT, Hospitals, Patient Engagement
QliqSOFT, CPSI to offer Covid-19 vaccine chatbot to community hospitals
The COVID-19 Vaccination Assistant will provide information about the new vaccines to help allay fears among the U.S. public. It will also help people schedule their vaccinations and connect them with rideshare services to make it to their appointment.
-
Take it from an expert: Fauci’s hierarchy of safety during Covid
A health journalist, a physician and a former foreign correspondent sits down with Dr. Anthony Fauci for a lengthy Q&A about safety during Covid times.
-
States’ face-covering mandates leave gaps in protection
Bandannas, like plastic face shields, allow the virus to escape out the bottom in aerosolized particles that can hang in the air for hours. And gaiters are often made of such thin material that they don’t trap as much virus as cloth masks.